Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
Proc Natl Acad Sci U S A ; 117(20): 11038-11047, 2020 05 19.
Article in English | MEDLINE | ID: mdl-32366663

ABSTRACT

Dengue virus (DENV) is a global health threat, causing repeated epidemics throughout the tropical world. While low herd immunity levels to any one of the four antigenic types of DENV predispose populations to outbreaks, viral genetic determinants that confer greater fitness for epidemic spread is an important but poorly understood contributor of dengue outbreaks. Here we report that positive epistasis between the coding and noncoding regions of the viral genome combined to elicit an epidemiologic fitness phenotype associated with the 1994 DENV2 outbreak in Puerto Rico. We found that five amino acid substitutions in the NS5 protein reduced viral genomic RNA (gRNA) replication rate to achieve a more favorable and relatively more abundant subgenomic flavivirus RNA (sfRNA), a byproduct of host 5'-3' exoribonuclease activity. The resulting increase in sfRNA relative to gRNA levels not only inhibited type I interferon (IFN) expression in infected cells through a previously described mechanism, but also enabled sfRNA to compete with gRNA for packaging into infectious particles. We suggest that delivery of sfRNA to new susceptible cells to inhibit type I IFN induction before gRNA replication and without the need for further de novo sfRNA synthesis could form a "preemptive strike" strategy against DENV.


Subject(s)
3' Untranslated Regions/genetics , Dengue Virus/genetics , Dengue/virology , Viral Nonstructural Proteins/genetics , A549 Cells , Dengue/epidemiology , Epistasis, Genetic , Exoribonucleases , Gene Knockout Techniques , Genome, Viral , HEK293 Cells , Host-Pathogen Interactions , Humans , Interferon Type I/metabolism , Microtubule-Associated Proteins , Mutation , Puerto Rico/epidemiology , RNA, Guide, Kinetoplastida/metabolism , Virus Replication
2.
J Biol Chem ; 278(37): 34975-82, 2003 Sep 12.
Article in English | MEDLINE | ID: mdl-12826671

ABSTRACT

Escherichia coli possesses a two-domain flavohemoglobin, Hmp, implicated in nitric oxide (NO) detoxification. To determine the contribution of each domain of Hmp toward NO detoxification, we genetically engineered the Hmp protein and separately expressed the heme (HD) and the flavin (FD) domains in a defined hmp mutant. Expression of each domain was confirmed by Western blot analysis. CO-difference spectra showed that the HD of Hmp can bind CO, but the CO adduct showed a slightly blue-shifted peak. Overexpression of the HD resulted in an improvement of growth to a similar extent to that observed with the Vitreoscilla hemeonly globin Vgb, whereas the FD alone did not improve growth. Viability of the hmp mutant in the presence of lethal concentrations of sodium nitroprusside was increased (to 30% survival after 2 h in 5 mM sodium nitroprusside) by overexpressing Vgb or the HD. However, maximal protection was provided only by holo-Hmp (75% survival under the same conditions). Cellular respiration of the hmp mutant was instantaneously inhibited in the presence of 13.5 microM NO but remained insensitive to NO inhibition when these cells overexpressed Hmp. When HD or FD was expressed separately, no significant protection was observed. By contrast, overexpression of Vgb provided partial protection from NO respiratory inhibition. Our results suggest that, despite the homology between the HD from Hmp and Vgb (45% identity), their roles seem to be quite distinct.


Subject(s)
Dihydropteridine Reductase/physiology , Escherichia coli Proteins/physiology , Escherichia coli/metabolism , Heme/metabolism , Hemeproteins/physiology , NADH, NADPH Oxidoreductases/physiology , Nitric Oxide/pharmacology , Nitroprusside/pharmacology , Oxygen Consumption/drug effects , Amino Acid Sequence , Binding Sites , Carbon Monoxide/metabolism , Cell-Free System , Dihydropteridine Reductase/chemistry , Escherichia coli/drug effects , Escherichia coli/genetics , Escherichia coli Proteins/chemistry , Genotype , Hemeproteins/chemistry , Kinetics , Molecular Sequence Data , NADH, NADPH Oxidoreductases/chemistry , Peptide Fragments/physiology , Sequence Alignment , Sequence Homology, Amino Acid
SELECTION OF CITATIONS
SEARCH DETAIL